Co-Development, Co-Promotion, Marketing and Licensing Agreement Sample Contracts

Co-development, co-promotion, marketing and licensing agreement for Contrave (naltrexone SR/bupropion SR)

Co-Development, Co-Promotion, Marketing and Licensing Agreement • October 13th, 2021 • New York

• Contract Type
  Co-Development, Co-Promotion, Marketing and Licensing Agreement
• Filed
  October 13th, 2021
• Jurisdiction
  New York

Takeda Pharmaceuticals (TKPYY) will return the U.S. rights to the anti-obesity drug Contrave to its partnerOrexigen (OREX), the company announced this morning.